Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life

Digestive Diseases and Sciences
C M HuntD M Williams

Abstract

Studies of interferon-alpha (IFN-alpha) therapy for chronic hepatitis C have focused on viral clearance; however, few have evaluated patient's health-related quality of life during therapy. This study evaluates health-related quality of life and the prevalence of anxiety and depression in patients with chronic hepatitis C before, during, and following IFN-alpha therapy. Patients undergoing IFN-alpha therapy for chronic hepatitis C were asked to complete health status measures as well as anxiety and depression inventories before, during, and following IFN-alpha therapy. These measures were compared to the results of healthy adults in the general US population. Thirty-eight of forty-eight eligible patients (79%) with chronic hepatitis C completed the questionnaires. Respondents demonstrated a significant increase in depression during the sixth month of interferon therapy in comparison to pretreatment results. Anxiety scores improved significantly after one month of IFN-alpha in comparison to pretreatment results. Scores on the health status measures did not vary with IFN-alpha therapy. Patient responses were analyzed with respect to biochemical response (normalized transaminases) to IFN-alpha. IFN-alpha responders, who were aware...Continue Reading

Citations

Jun 16, 2001·Transfusion·A Pereira
Apr 25, 2001·Journal of Clinical Gastroenterology·J ObhraiB S Anand
Apr 23, 2002·Journal of Gastroenterology and Hepatology·Jennifer McDonaldSonja Gluseska
Jul 23, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Bénédicte GohierJean-Bernard Garré
Mar 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brennan M R SpiegelFasiha Kanwal
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michaël SchwarzingerMostafa Kamal Mohamed
Mar 4, 2005·The American Journal of Gastroenterology·Hla-Hla TheinGregory J Dore
Jan 12, 2008·International Journal of Methods in Psychiatric Research·Arne SchäferMichael R Kraus
Mar 26, 2011·Future Neurology·Ghanshyam N Pandey, Yogesh Dwivedi
Oct 17, 2018·European Journal of Gastroenterology & Hepatology·Kathrin KrügerUNKNOWN Collaborators DHC-R
Jan 20, 2019·International Journal of Environmental Research and Public Health·Thuc Thi Minh VuRoger C M Ho
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H L Bonkovsky, J M Woolley
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R S Koff
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L CapuronR Dantzer
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David BernsteinJesse Green
Oct 16, 2004·Liver International : Official Journal of the International Association for the Study of the Liver·Yuji TanakaHisataka Moriwaki
Jun 12, 2010·Annals of the New York Academy of Sciences·Kenneth E Sherman
May 29, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D ZdilarZ M Younossi
Dec 17, 2003·Journal of Gastroenterology and Hepatology·Hla-Hla TheinGregory J Dore
Apr 21, 2004·European Journal of Gastroenterology & Hepatology·Cristina PojogaDana Damian
Jan 30, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·D E Fransen Van De PutteE P Mauser-Bunschoten
Apr 25, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·Klaus LiebMartin Schaefer
Jul 26, 2006·Digestive Diseases and Sciences·Claudio R TombazziCaroline A Riely
Sep 23, 2008·Journal of General Internal Medicine·Erik J GroesslSamuel B Ho
Jan 24, 2007·International Journal of Psychiatry in Medicine·Mine OzkanGültürk Köroglu
Apr 24, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hisami Yamanaka-OkumuraEiji Takeda
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair YounossiJohn Kincaid
Apr 16, 2005·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Jana C Saunders, Craig A Cookman
Feb 24, 2001·The American Journal of Gastroenterology·R J FontanaS Webster
Aug 19, 2004·European Journal of Gastroenterology & Hepatology·P BurraM Dam
May 10, 2002·Journal of Gastroenterology and Hepatology·Hans Glise, Ingela Wiklund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.